Detalhe da pesquisa
1.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
N Engl J Med
; 389(4): 335-347, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272512
2.
Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T-cell therapy.
Eur J Haematol
; 112(3): 371-378, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879842
3.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Lancet Oncol
; 24(8): 913-924, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414060
4.
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 200(2): 187-196, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210485
5.
Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.
Br J Haematol
; 196(3): 649-659, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622447
6.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
Blood
; 136(18): 2038-2050, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731259
7.
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy.
Br J Haematol
; 193(1): 181-187, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469083
8.
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
Br J Haematol
; 193(2): 299-306, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200406
9.
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Br J Haematol
; 194(3): 496-507, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724461
10.
Kidney Transplantation in Monoclonal Immunoglobulin Deposition Disease: A Report of 6 Cases.
Am J Kidney Dis
; 78(5): 755-759, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961923
11.
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
Ann Hematol
; 100(12): 2997-3005, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463804
12.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.
J Immunol
; 200(8): 2581-2591, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531171
13.
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
Eur J Haematol
; 102(5): 389-394, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719772
14.
Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma.
Int J Mol Sci
; 19(11)2018 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445802
15.
Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis.
Biol Blood Marrow Transplant
; 23(8): 1269-1275, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434927
16.
How I treat relapsed myeloma.
Blood
; 125(10): 1532-40, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25587037
17.
A practical approach to the diagnosis of systemic amyloidoses.
Blood
; 125(14): 2239-44, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636337
18.
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
Oncologist
; 21(3): 333-42, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26921288
19.
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.
Br J Haematol
; 170(6): 804-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25974382
20.
Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL).
Ann Hematol
; 99(12): 2961-2962, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862282